Ф. М. Урманова

Ф. М. Урманова

Auto-generated profile, based on publicly available information

Ф. М. Урманова

Ташкентский государственный стоматологический институт

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2023 in Advanced Ophthalmology
Verified
Journal Article
Open access
PDF file
ФУФ. М Урманова
Ф. М Урманова
ФБФ. А. Бахритдинова
Ф. А. Бахритдинова
ААА. А. Ахраров
А. А. Ахраров
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
Relevance. Despite modern advances in medicine, type 2 diabetes mellitus (DM 2) still remains an important medical and social problem due to the frequency and severity of complications. The purpose of our study. The aim of the study was to evaluate the relationship between the levels of vascular growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) in blood serum and the area of the foveal avascular zone (FAZ) on OCT-A in patients with type 2 diabetes mellitus (DM2), with various stages DR. Materials and methods. A clinical study was conducted among 252 people (n=504), of which 168 patients with type 2 diabetes and 84 practically healthy individuals, the average age of which was 57.6 ± 7.8 years, of which 52.6% were men, 47.4% women. Results. As a result of the studies, an increase in the level of VEGF in the blood serum before the onset of DR clinically was revealed 137.2 ± 84.4 pg/ml (group II of comparison). It was found that the level of VEGF correlated with the levels of BDNF in the serum of patients and with the stage of retinopathy (p<0.05). Based on the studies performed, it was suggested that a mild deficiency with plasma BDNF less than 0.62 ng/ml indicates DR in general, and a BDNF level < 0.22 ng/ml indicates the development of PDR and/or diabetic macular ischemia (DME). Thus, a low level of BDNF and a high level of VEGF in serum can be potential risk factors for DR in T2 DM and serve as its diagnostic indicators.

13 August 2025 in Advanced Ophthalmology
Verified
Journal Article
Open access
PDF file
БФБахритдинова Ф.а.
Бахритдинова Ф.а.
УФУрманова Ф.м.
Урманова Ф.м.
ТДТуйчибаева Д.м.
Туйчибаева Д.м.
Relevance. Diabetic retinopathy (DR) is one of the main causes of incurable blindness and visual disability among adults. A number of scientific studies are conducted for the purpose of effective prevention and treatment of DR, however, issues related to methods of preventing the occurrence of DR in individuals with type 2 diabetes mellitus and the progression of DR have not been sufficiently studied. Purpose of the study. To study the effectiveness of drug prevention of the occurrence of DR and the progression of DR among patients with type 2 diabetes. Material and methods. A total of 168 patients (n=336 eyes) with type 2 diabetes were examined, who were divided into 2 groups depending on the drug treatment: Group 1A: 81 patients (n=162 eyes) without diabetic retinopathy and Group 2B - 87 patients (n=174 eyes) with mild and moderate NPDR. Results and conclusion. As a result of the conducted studies, negative dynamics of blood flow density in the lower hemisphere, Vsist of blood flow in the PSCA, BDNF and VEGF parameters in the TF after a course of traditional treatment were established. Positive results were obtained when studying the parameters of OCT-A, USODG, BDNF and VEGF while taking calcium Dobesylate and Semax preparations 0.1% higher than the initial values. An analysis of the results of the study showed the high effectiveness of the proposed method for preventing the occurrence and progression of diabeticretinopathy in people with type 2 diabetes.

16 June 2025 in Advanced Ophthalmology
Verified
Journal Article
Open access
PDF file
TDTuychibaeva D.M.
Tuychibaeva D.M.
ALAdhamova L.A.
Adhamova L.A.
Relevance. Among other retinopathies, central serous chorioretinopathy (CSC) ranks fourth in the incidence structure after age-related macular degeneration (AMD), diabetic retinopathy and retinal vein occlusion. Purpose of the study. To study the effectiveness of subthreshold micropulse laser exposure with a wavelength of 577 nm in the complex treatment of central serous chorioretinopathy. Materials and methods. The clinical study is based on the analysis of the CRC of 121 eyes of 121 patients with unilateral CSC. Among the subjects: 23 (19%) women and 98 (81%) men. The age of the participants was 40.8 ± 6.4 years. Results and conclusion. A protocol of SMLV with a wavelength of 577 nm was developed and introduced into clinical practice, which is safe and effective in the treatment of CSC. The absence of laser-induced damage when using the energy parameters of the SMLV protocol with a wavelength of 577 nmallows for treatment in the early acute period of CSC, in the phase of acute phase, with diffuse hyperfluorescence, and for repeating sessions during persistence and relapses of the process. Combined analysis of OCT, HF AF and IR-AF data allows for identifying the features of structural and functional changes in CRC in CSC, accurately determining the duration of the disease and predicting the functional outcome after the process has been resolved.

21 May 2025 in Advanced Ophthalmology
Verified
Journal Article
Open access
PDF file
ТДТуйчибаева Д.м.
Туйчибаева Д.м.
АЛАдхамова Л.а.
Адхамова Л.а.
Relevance. Central serous chorioretinopathy (CSC) is a chronic disease characterized by idiopathic serous neurosensory retinal detachment and/or retinal pigment epithelium (RPE) detachment, with changes, most often limited to the macula and associated with impaired barrier, transport, pumping, and cytokine-producing functions of the RPE, increased permeability of Bruch's membrane, and fluid seepage from the choriocapillaries through the RPE into the subretinal space. Purpose of the study. To evaluate the efficacy and safety of application of subthreshold micropulse laser therapy with the wavelength of 577 nm in the treatment of central serous chorioretinopathy. Materials and methods. 23 patients (23 eyes) were included in the study. The patients' age ranged from 41 to 58 years. Among the patients there were 10 women and 13 men. Laser treatment was performed on the “IRIDEX IQ 577” (IRIDEX Corporation, Mountain View, USA) with yellow (577 nm) wavelength of radiation, which allows to work both in micropulse and continuous modes. Results and conclusion. Positive dynamics was observed in all cases during the follow-up, by the end of the follow-up period all patients noted improvement of vision, reduction of distortions. After laser treatment in 35.7% of cases of the main group there was a complete adhesion of serous ONE of the retinae, while in 64.3% of cases subretinal fluid remained. In the control group after focal LCS, complete resorption of ONE was detected in the majority of cases, while in 36% of cases the process persisted. By the period of 12 months the disease recurrence was detected in 8% of cases, and ONE adherence was determined in 92%. Micropulse laserexposure has shown its effectiveness in the treatment of long-term and recurrent chronic central serous chorioretinopathy and allows to perform multiple, repeated laser interventions without laser-induced damage.

22 February 2023 in Advanced Ophthalmology
Verified
Journal Article
Open access
PDF file
GKGuzal E Kangilbaeva
Guzal E Kangilbaeva
ФБФ. А. Бахритдинова
Ф. А. Бахритдинова
ФУФ. М. Урманова
Ф. М. Урманова
Relevance. The aim of this study was to determine the correlation of indicators of nitric oxide and oxidative stress of the lacrimal fluid with the severity of non-proliferative diabetic retinopathy. Materials and methods. Clinical studies were conducted during the treatment of 36 patients (69 eyes) diagnosed with non-proliferative diabetic retinopathy (NDR). Patients underwent a general ophthalmological examination and biochemical studies of the lacrimal fluid. Results. Studies have shown a gradual decrease in nitric oxide levels as DR worsens. In patients with NDR 1a severity, the level of nitric oxide decreased statistically significantly by 22.3% (P<0.001), and in 1c severity this level decreased by 66.7% (P<0.001) relative to the values of practically healthy individuals and by 57.1% (P<0.001) compared with the indices of patients with 1a NDR severity. Conclusion. The severity of NDR is directly related to the level of nitric oxide in the lacrimal fluid of patients: as the content of nitric oxide decreases, progression of retinopathy is observed. The imbalance in the POL-AOS system has a staged character.